FDA Inspection 1176891 — Richard L. Wasserman, MD

Richard L. Wasserman, MD — FEI 3012430379

The FDA completed an inspection of Richard L. Wasserman, MD on Jul 29, 2022 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 29, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)